These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 9673227)
1. Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance. James SL; Cheever AW; Caspar P; Wynn TA Infect Immun; 1998 Aug; 66(8):3510-8. PubMed ID: 9673227 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide produced in the lungs of mice immunized with the radiation-attenuated schistosome vaccine is not the major agent causing challenge parasite elimination. Coulson PS; Smythies LE; Betts C; Mabbott NA; Sternberg JM; Wei XG; Liew FY; Wilson RA Immunology; 1998 Jan; 93(1):55-63. PubMed ID: 9536119 [TBL] [Abstract][Full Text] [Related]
3. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. Hoffmann KF; James SL; Cheever AW; Wynn TA J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689 [TBL] [Abstract][Full Text] [Related]
4. Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide. Oswald IP; Eltoum I; Wynn TA; Schwartz B; Caspar P; Paulin D; Sher A; James SL Proc Natl Acad Sci U S A; 1994 Feb; 91(3):999-1003. PubMed ID: 7508126 [TBL] [Abstract][Full Text] [Related]
5. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. Wynn TA; Jankovic D; Hieny S; Cheever AW; Sher A J Immunol; 1995 May; 154(9):4701-9. PubMed ID: 7722323 [TBL] [Abstract][Full Text] [Related]
6. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. Wynn TA; Reynolds A; James S; Cheever AW; Caspar P; Hieny S; Jankovic D; Strand M; Sher A J Immunol; 1996 Nov; 157(9):4068-78. PubMed ID: 8892641 [TBL] [Abstract][Full Text] [Related]
7. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. Wynn TA; Oswald IP; Eltoum IA; Caspar P; Lowenstein CJ; Lewis FA; James SL; Sher A J Immunol; 1994 Dec; 153(11):5200-9. PubMed ID: 7525727 [TBL] [Abstract][Full Text] [Related]
8. In the absence of CD154, administration of interleukin-12 restores Th1 responses but not protective immunity to Schistosoma mansoni. Hewitson JP; Hamblin PA; Mountford AP Infect Immun; 2007 Jul; 75(7):3539-47. PubMed ID: 17485453 [TBL] [Abstract][Full Text] [Related]
9. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection. Pemberton RM; Wilson RA Immunology; 1995 Feb; 84(2):310-6. PubMed ID: 7751008 [TBL] [Abstract][Full Text] [Related]
10. ICAM-1 and iNOS expression increased in the skin of mice after vaccination with gamma-irradiated cercariae of Schistosoma mansoni. Ramaswamy K; He YX; Salafsky B Exp Parasitol; 1997 Jun; 86(2):118-32. PubMed ID: 9207742 [TBL] [Abstract][Full Text] [Related]
11. Schistosoma mansoni: protective immunity in IL-4-deficient mice. King CL; Malhotra I; Jia X Exp Parasitol; 1996 Nov; 84(2):245-52. PubMed ID: 8932774 [TBL] [Abstract][Full Text] [Related]
12. Radiation-resistant acquired immunity of vaccinated mice to Schistosoma mansoni. Aitken R; Coulson PS; Dixon B; Wilson RA Am J Trop Med Hyg; 1987 Nov; 37(3):570-7. PubMed ID: 3120610 [TBL] [Abstract][Full Text] [Related]
13. Immunity to Schistosoma mansoni in mice vaccinated with irradiated cercariae: cytokine interactions in the pulmonary protective response. Smythies LE; Coulson PS; Wilson RA Ann Trop Med Parasitol; 1993 Dec; 87(6):653-7. PubMed ID: 8122929 [TBL] [Abstract][Full Text] [Related]
14. Kinetics and mechanism of effector focus formation in the lungs of mice vaccinated with irradiated cercariae of Schistosoma mansoni. Smythies LE; Betts C; Coulson PS; Dowling MA; Wilson RA Parasite Immunol; 1996 Jul; 18(7):359-69. PubMed ID: 9229389 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. Smythies LE; Coulson PS; Wilson RA J Immunol; 1992 Dec; 149(11):3654-8. PubMed ID: 1431135 [TBL] [Abstract][Full Text] [Related]
16. Interferon gamma is a key cytokine in lung phase immunity to schistosomes but what is its precise role? Wilson RA Braz J Med Biol Res; 1998 Jan; 31(1):157-61. PubMed ID: 9686194 [TBL] [Abstract][Full Text] [Related]
17. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms. Jankovic D; Wynn TA; Kullberg MC; Hieny S; Caspar P; James S; Cheever AW; Sher A J Immunol; 1999 Jan; 162(1):345-51. PubMed ID: 9886405 [TBL] [Abstract][Full Text] [Related]
18. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone. Fonseca CT; PacĂfico LG; Barsante MM; Rassi T; Cassali GD; Oliveira SC Microbes Infect; 2006 Aug; 8(9-10):2509-16. PubMed ID: 16914349 [TBL] [Abstract][Full Text] [Related]
19. The debate over the effector function of eosinophils in helminth infection: new evidence from studies on the regulation of vaccine immunity by IL-12. Wynn TA Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():105-8. PubMed ID: 9698921 [TBL] [Abstract][Full Text] [Related]
20. Systems Biology Analysis of the Radiation-Attenuated Schistosome Vaccine Reveals a Role for Growth Factors in Protection and Hemostasis Inhibition in Parasite Survival. Farias LP; Vitoriano-Souza J; Cardozo LE; Gama LDR; Singh Y; Miyasato PA; Almeida GT; Rodriguez D; Barbosa MMF; Fernandes RS; Barbosa TC; Neto APDS; Nakano E; Ho PL; Verjovski-Almeida S; Nakaya HI; Wilson RA; Leite LCC Front Immunol; 2021; 12():624191. PubMed ID: 33777004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]